Association of VEGF Gene Polymorphisms with the Risk and Prognosis of Cutaneous Squamous Cell Carcinoma

Autor: Li Zhang, Xiao-juan Nie, Wen-min Liu
Rok vydání: 2016
Předmět:
0301 basic medicine
Adult
Male
Vascular Endothelial Growth Factor A
medicine.medical_specialty
China
Single-nucleotide polymorphism
Biology
Gastroenterology
Polymorphism
Single Nucleotide

03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Gene Frequency
Clinical Research
Internal medicine
Genotype
medicine
Carcinoma
Humans
Genetic Predisposition to Disease
Allele
Allele frequency
Alleles
Genetic Association Studies
Polymorphism
Single-Stranded Conformational

Aged
Case-control study
General Medicine
Middle Aged
medicine.disease
Prognosis
Vascular endothelial growth factor
030104 developmental biology
chemistry
030220 oncology & carcinogenesis
Case-Control Studies
Cancer research
Carcinoma
Squamous Cell

Female
Vascular Endothelial Growth Factor
Endocrine-Gland-Derived

Skin cancer
Zdroj: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
ISSN: 1643-3750
Popis: Background Cutaneous squamous cell carcinoma (cSCC) is the second most common type of non-melanoma skin cancer (NMSC) globally. The aims of this study were to further systematically clarify the potential association of rs833061 (-460 C>T) and rs1570360 (-1154 G>A), two SNPs of VEGF, with the risk of cSCC and the prognostic impacts on cSCC patients. Material/Methods This hospital-based case-control study analyzed peripheral venous blood collected from 100 cSCC patients and 124 healthy controls, and gathered personal information on patients. Genotypes of the VEGF gene -460C>T and -1154G>A polymorphism were detected using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method. Different distributions of allele frequencies and genotype in the case and control group were measured, comparing different genotype differences in the survival of patients with cSCC. Results Distributions of allele frequencies and genotype of -460 C>T in the case and control group were statistically different; the TT + CT genotype was significantly correlated with a decrease risk of cSCC (OR=0.36, 95% CI=0.21–0.63, PA between control and case groups. For -1154460C>T, the CC genotype was an adverse factor, associated with a significant decrease in the survival status of cSCC patients (PA, the AA genotype was significantly correlated with the reduced overall survival in cSCC patients, with the mean survival time of 23.88 months (P=0.009). Conclusions The VEGF gene -460 C>T polymorphism and -1154 G>A polymorphism may serve as potential genetic markers for the risk and prognosis of cSCC.
Databáze: OpenAIRE